{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:15:36Z","timestamp":1768418136473,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajoc.2024.102031","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T07:22:28Z","timestamp":1709364148000},"page":"102031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8599-4837","authenticated-orcid":false,"given":"David A.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5480-5523","authenticated-orcid":false,"given":"Roger E.","family":"Turbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajoc.2024.102031_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med. Feb 25"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102031_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1067\/mjd.2003.323","article-title":"Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease","volume":"48","author":"Anderson","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.ajoc.2024.102031_bib3","doi-asserted-by":"crossref","first-page":"S458","DOI":"10.1007\/s00259-002-0813-6","article-title":"Management of thyroid eye disease","volume":"29","author":"Bartalena","year":"2002","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102031_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2021.04.024","article-title":"Teprotumumab: interpreting the clinical trials in the context of thyroid eye disease pathogenesis and current therapies","volume":"128","author":"Winn","year":"2021","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajoc.2024.102031_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jdcr.2020.09.003","article-title":"Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease","volume":"6","author":"Varma","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102031_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bjd.21700","article-title":"Teprotumumab as a novel treatment for pretibial myxoedema","volume":"187","author":"Mervis","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajoc.2024.102031_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdcr.2021.08.026","article-title":"A case of pretibial myxedema treated with teprotumumab","volume":"16","author":"Petit","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.ajoc.2024.102031_bib8","first-page":"2022","article-title":"Thyroid dermopathy responds to teprotumumab therapy","author":"Crespo-Trevino","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102031_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41433-018-0321-y","article-title":"Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis","volume":"33","author":"Douglas","year":"2019","journal-title":"Eye"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:38:50Z","timestamp":1716291530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":9,"alternative-id":["S2451993624000410"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102031","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102031"}}